Description
Hamps Bio Limited provides revised undertaking for crediting bonus shares to beneficiaries by September 10, 2025, with trading to commence September 11, 2025.
Summary
Hamps Bio Limited (Scrip Code: 544312, ISIN: INEOQBD01018) has submitted a revised undertaking to BSE regarding the crediting of bonus shares to beneficiaries’ accounts. The company commits to credit up to 43,56,000 bonus shares by 12:00 PM on September 10, 2025, with trading to commence on September 11, 2025.
Key Points
- Revised record date: September 09, 2025
- Share crediting deadline: September 10, 2025 by 12:00 PM (T+1)
- Trading commencement: September 11, 2025 at beginning of day (T+2)
- Maximum bonus shares: 43,56,000
- Distinctive numbers: 43,56,001 to 87,12,000
- Deemed allotment date: September 10, 2025
Regulatory Changes
No regulatory changes introduced. This circular represents compliance with existing SEBI Circular No. SEBI/CFD/PoD/2024/122 dated September 16, 2024, regarding bonus share crediting timelines.
Compliance Requirements
- Company must credit bonus shares to depository accounts by 12:00 PM on T+1 day
- Shares must be available for trading at BOD on T+2 day
- Undertaking submitted as per BSE requirements and SEBI guidelines
- Company must maintain distinctive number allocation as specified
Important Dates
- Record Date: September 09, 2025
- Share Crediting Deadline: September 10, 2025 (12:00 PM)
- Trading Commencement: September 11, 2025 (BOD)
- Deemed Allotment Date: September 10, 2025
Impact Assessment
Medium impact on Hamps Bio Limited shareholders who will receive bonus shares in 1:1 ratio based on the share count. The defined timeline ensures orderly processing of corporate action with minimal market disruption. Trading resumption on T+2 follows standard market practices for bonus issues.
Impact Justification
Standard corporate action affecting single stock with defined timeline and regulatory compliance requirements